d-alpha tocopherol has been researched along with Left Ventricular Dysfunction in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Alpenglow, JK; Bunsawat, K; Drakos, SG; Jarrett, CL; Park, SH; Ratchford, SM; Richardson, RS; Stehlik, J; Wray, DW | 1 |
| Beyer, AJ; Chen, J; Chen, Q; Gerdes, AM; Harris, WS; Healy, CL; Nareddy, VB; O'Connell, TD; Shearer, GC; Wang, D | 1 |
| Bauer, F; Isabelle, M; Monteil, C; Moritz, F; Mulder, P; Renet, S; Richard, V; Thuillez, C | 1 |
| Belló-Klein, A; Clausell, N; Geib, G; Mazzotti, NG; Pereira, RP; Rohde, LE; Silva, LF; Weber, C | 1 |
| Levantesi, G; Macchia, A; Marchioli, R; Marfisi, RM; Nicolosi, GL; Tavazzi, L; Tognoni, G; Valagussa, F | 1 |
| Seymen, AA; Tandogan, B; Tanriverdi, E; Tuncay, E; Turan, B; Ulusu, NN; Yaras, N | 1 |
6 other study(ies) available for d-alpha tocopherol and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Chronic antioxidant administration restores macrovascular function in patients with heart failure with reduced ejection fraction.
Topics: Aged; Antioxidants; Ascorbic Acid; Biomarkers; Case-Control Studies; Female; Heart Failure; Humans; Hyperemia; Male; Middle Aged; Oxidative Stress; Prospective Studies; Thioctic Acid; Ventricular Dysfunction, Left; Vitamin E | 2020 |
Omega-3 fatty acids prevent pressure overload-induced cardiac fibrosis through activation of cyclic GMP/protein kinase G signaling in cardiac fibroblasts.
Topics: Animals; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Dietary Supplements; Fatty Acids, Omega-3; Fibroblasts; Fibrosis; Heart Ventricles; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase Type III; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta1; Up-Regulation; Ventricular Dysfunction, Left; Ventricular Remodeling; Vitamin E | 2011 |
Role of reactive oxygen species in cocaine-induced cardiac dysfunction.
Topics: Animals; Antioxidants; Ascorbic Acid; Cocaine; Echocardiography; Glutathione Peroxidase; Lipid Peroxidation; Male; Myocardium; NADPH Oxidases; Random Allocation; Rats; Rats, Wistar; Reactive Oxygen Species; RNA, Messenger; Superoxide Dismutase; Vasoconstrictor Agents; Ventricular Dysfunction, Left; Vitamin E | 2003 |
Superoxide dismutase activity in adriamycin-induced cardiotoxicity in humans: a potential novel tool for risk stratification.
Topics: Antibiotics, Antineoplastic; Antioxidants; Biomarkers; Chromans; Doxorubicin; Erythrocytes; Female; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasms; Predictive Value of Tests; Prospective Studies; Radionuclide Ventriculography; ROC Curve; Stroke Volume; Superoxide Dismutase; Ventricular Dysfunction, Left; Vitamin E | 2005 |
Vitamin E increases the risk of developing heart failure after myocardial infarction: Results from the GISSI-Prevenzione trial.
Topics: Antioxidants; Fatty Acids, Omega-3; Female; Follow-Up Studies; Heart Failure; Humans; Incidence; Italy; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Factors; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Vitamin E | 2006 |
Gender related differential effects of Omega-3E treatment on diabetes-induced left ventricular dysfunction.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Drug Combinations; Fatty Acids, Omega-3; Female; Heart Ventricles; Male; Models, Biological; Rats; Rats, Wistar; Sex Characteristics; Streptozocin; Ventricular Dysfunction, Left; Vitamin E | 2007 |